Literature DB >> 17542759

Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.

Alan P Avakian1, Rebecca M Poston, Fan-kun Kong, Kent R Van Kampen, De-chu C Tang.   

Abstract

Automated in ovo vaccination is an efficient method for mass immunization of poultry. Although in ovo vaccination has been used to mass immunize chickens against several infectious diseases, there are common poultry diseases for which in ovo-compatible vaccines are not commercially available. It was recently demonstrated that in ovo administration of a nonreplicating human adenovirus vector encoding an avian influenza virus hemagglutinin induced protective immunity against highly pathogenic avian influenza. The advantages of this new class of poultry vaccine include in ovo delivery of a wide variety of pathogen-derived antigens, high potency in a single-dose regimen, rapid production in response to increased demand, no replication of the vector, no pre-existing immunity to human adenovirus in chickens, compatibility with automated in ovo administration and no interference with epidemiological surveys of natural infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17542759     DOI: 10.1586/14760584.6.3.457

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  3 in total

1.  Assessment of route of administration and dose escalation for an adenovirus-based influenza A Virus (H5N1) vaccine in chickens.

Authors:  Julia Steitz; Robert A Wagner; Tyler Bristol; Wentao Gao; Ruben O Donis; Andrea Gambotto
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

Review 2.  Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines.

Authors:  De-chu C Tang; Jianfeng Zhang; Haroldo Toro; Zhongkai Shi; Kent R Van Kampen
Journal:  Expert Rev Vaccines       Date:  2009-04       Impact factor: 5.217

3.  Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine.

Authors:  Jake Astill; Tamiru Alkie; Alexander Yitbarek; Khaled Taha-Abdelaziz; Jegarubee Bavananthasivam; Éva Nagy; James John Petrik; Shayan Sharif
Journal:  BMC Res Notes       Date:  2018-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.